13D/G large-stake feed

Latest 13D/G Reports

Since 04 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13G/A

Paradigm Biocapital Advisors LP stake in EyePoint, Inc.

Holder CIK 0001855655

13G/A EYPT
CIK
0001855655
Issuer
EyePoint, Inc.
Security
EYPT
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
3.8% / 3,142,437 shares
Filed
15 May 2026, 16:26:16 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Point72 Asset Management, L.P. stake in CYBIN INC.

Holder CIK 0001603466

13G/A CYBN
CIK
0001603466
Issuer
CYBIN INC.
Security
CYBN
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
1.4% / 686,669 shares
Filed
15 May 2026, 16:26:06 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Paradigm Biocapital Advisors LP stake in UroGen Pharma Ltd.

Holder CIK 0001855655

13G/A URGN
CIK
0001855655
Issuer
UroGen Pharma Ltd.
Security
URGN
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
3.5% / 1,703,949 shares
Filed
15 May 2026, 16:25:57 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

STEADFAST CAPITAL MANAGEMENT LP stake in Planet Fitness, Inc.

Holder CIK 0001214822

13G/A PLNT
CIK
0001214822
Issuer
Planet Fitness, Inc.
Security
PLNT
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
2.8% / 2,212,592 shares
Filed
15 May 2026, 16:25:57 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Norwest Venture Partners XIII, LP stake in Talkspace, Inc.

Holder CIK 0001772583

13G/A TALK
CIK
0001772583
Issuer
Talkspace, Inc.
Security
TALK
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
0% / 0 shares
Filed
15 May 2026, 16:25:47 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Paradigm Biocapital Advisors LP stake in Lexeo Therapeutics, Inc.

Holder CIK 0001855655

13G/A LXEO
CIK
0001855655
Issuer
Lexeo Therapeutics, Inc.
Security
LXEO
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
8.3% / 6,184,134 shares
Filed
15 May 2026, 16:25:34 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
901-950 of 4,054
Per page
50
Current page
19

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

0/6

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

8.3%

Highest class ownership surfaced in the preview cards.

Newest evidence

15 May 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

Paradigm Biocapital Advisors LP

EyePoint, Inc. (EYPT)

Schedule 13G/A Ownership 3.8% Filing-backed
CIK
000110465926062616
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
3.8%
Filed
15 May 2026, 16:26:16 UTC
Period
31 Mar 2026

Paradigm Biocapital Advisors LP filed Schedule 13G/A for EyePoint, Inc. (EYPT). Reported class ownership: 3.8%. Ownership change: -1.3%. Share change: -25%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Point72 Asset Management, L.P.

CYBIN INC. (CYBN)

Schedule 13G/A Ownership 1.4% Filing-backed
CIK
000091957426003491
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
1.4%
Filed
15 May 2026, 16:26:06 UTC
Period
31 Mar 2026

Point72 Asset Management, L.P. filed Schedule 13G/A for CYBIN INC. (CYBN). Reported class ownership: 1.4%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Paradigm Biocapital Advisors LP

UroGen Pharma Ltd. (URGN)

Schedule 13G/A Ownership 3.5% Filing-backed
CIK
000110465926062615
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
3.5%
Filed
15 May 2026, 16:25:57 UTC
Period
31 Mar 2026

Paradigm Biocapital Advisors LP filed Schedule 13G/A for UroGen Pharma Ltd. (URGN). Reported class ownership: 3.5%. Ownership change: -5.5%. Share change: -60%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

STEADFAST CAPITAL MANAGEMENT LP

Planet Fitness, Inc. (PLNT)

Schedule 13G/A Ownership 2.8% Filing-backed
CIK
000101359426000607
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
2.8%
Filed
15 May 2026, 16:25:57 UTC
Period
31 Mar 2026

STEADFAST CAPITAL MANAGEMENT LP filed Schedule 13G/A for Planet Fitness, Inc. (PLNT). Reported class ownership: 2.8%. Ownership change: -3.6%. Share change: -58%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Norwest Venture Partners XIII, LP

Talkspace, Inc. (TALK)

Schedule 13G/A Ownership 0% Filing-backed
CIK
000177258326000003
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
0%
Filed
15 May 2026, 16:25:47 UTC
Period
31 Mar 2026

Norwest Venture Partners XIII, LP filed Schedule 13G/A for Talkspace, Inc. (TALK). Reported class ownership: 0%. Ownership change: -5.9%. Share change: -100%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Paradigm Biocapital Advisors LP

Lexeo Therapeutics, Inc. (LXEO)

Schedule 13G/A Ownership 8.3% Filing-backed
CIK
000110465926062613
Source
SEC Schedule 13G/A
Action
Large stake increase disclosed
Magnitude
8.3%
Filed
15 May 2026, 16:25:34 UTC
Period
31 Mar 2026

Paradigm Biocapital Advisors LP filed Schedule 13G/A for Lexeo Therapeutics, Inc. (LXEO). Reported class ownership: 8.3%. Ownership change: +1.8%. Share change: +30%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
Paradigm Biocapital Advisors LP CIK 0001855655 EYPT EyePoint, Inc. 3,142,437 3.8% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 CYBN CYBIN INC. 686,669 1.4% SEC filing
Paradigm Biocapital Advisors LP CIK 0001855655 URGN UroGen Pharma Ltd. 1,703,949 3.5% SEC filing
STEADFAST CAPITAL MANAGEMENT LP CIK 0001214822 PLNT Planet Fitness, Inc. 2,212,592 2.8% SEC filing
Norwest Venture Partners XIII, LP CIK 0001772583 TALK Talkspace, Inc. 0 0% SEC filing
Paradigm Biocapital Advisors LP CIK 0001855655 LXEO Lexeo Therapeutics, Inc. 6,184,134 8.3% SEC filing
Paradigm Biocapital Advisors LP CIK 0001855655 ERAS Erasca, Inc. 10,392,702 3.3% SEC filing
TCG Crossover GP II, LLC CIK 0001969280 SRZN Surrozen, Inc. 1,473,101 13% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 IVVD Invivyd, Inc. 43,931 0% SEC filing
Alyeska Investment Group, L.P. CIK 0001453072 BBCQU Bleichroeder Acquisition Corp. II 1,591,890 5.5% SEC filing
GENDELL JEFFREY L CIK 0001056581 NINE Nine Energy Service, Inc. 784,501 5.6% SEC filing
First Trust Capital Management L.P. CIK 0001604488 VACH Voyager Acquisition Corp./Cayman Islands 624,917 2.5% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 XLO Xilio Therapeutics, Inc. 0 0% SEC filing
TCG Crossover GP II, LLC CIK 0001969280 TNGX Tango Therapeutics, Inc. 11,597,737 8.1% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 KALV KalVista Pharmaceuticals, Inc. 2,136,940 4.2% SEC filing
Alyeska Investment Group, L.P. CIK 0001453072 BATL BATTALION OIL CORP 1,872,282 10% SEC filing
TCG Crossover GP II, LLC CIK 0001969280 GLUE Monte Rosa Therapeutics, Inc. 4,622,151 5.5% SEC filing
Alyeska Investment Group, L.P. CIK 0001453072 AZ A2Z CUST2MATE SOLUTIONS CORP. 0 0% SEC filing
Nextech Crossover I GP S.a r.l. CIK 0001916761 TNGX Tango Therapeutics, Inc. 7,266,081 5.1% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 RLAY Relay Therapeutics, Inc. 0 0% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 TNXP Tonix Pharmaceuticals Holding Corp. 1,100,964 6.9% SEC filing
Alyeska Investment Group, L.P. CIK 0001453072 AGIG ABUNDIA GLOBAL IMPACT GROUP, INC. 3,375,375 7.7% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 ANAB ANAPTYSBIO, INC 55,303 0.2% SEC filing
GENDELL JEFFREY L CIK 0001056581 BXC BlueLinx Holdings Inc. 739,523 9.4% SEC filing
MORGAN STANLEY CIK 0000895421 BEBE TGE Value Creative Solutions Corp 1,089,997 7.3% SEC filing
DISCIPLINED GROWTH INVESTORS INC /MN CIK 0001050442 KRNT Kornit Digital Ltd. 2,998,670 6.5% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 OVID Ovid Therapeutics Inc. 1,903,943 1.3% SEC filing
Foresite Capital Fund VI LP CIK 0001932516 VSTM Verastem, Inc. 3,146,631 3.6% SEC filing
HARRIS ASSOCIATES L P CIK 0000813917 WEN The Wendy's Company 5,929,801 3.1% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 IMNM Immunome Inc. 0 0% SEC filing
Menlo Ventures XIV, L.P. CIK 0001705785 CHYM CHIME FINANCIAL, INC. 9,807,210 2.8% SEC filing
Fund 1 Investments, LLC CIK 0001959730 WW WW INTERNATIONAL, INC. 779,629 7.8% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 CCCC C4 Therapeutics, Inc. 169,096 0.2% SEC filing
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC CIK 0001164833 NOV NOV Inc. 14,919,613 4.1% SEC filing
Bios Equity Partners, LP CIK 0001813314 LTRN Lantern Pharma Inc. 571,305 4.5% SEC filing
Hayon Joe Ronen CIK 0001911964 IINN Inspira Technologies OXY B.H.N. Ltd 2,544,474 5.7% SEC filing
Fund 1 Investments, LLC CIK 0001959730 JMIA Jumia Technologies AG 24,650,000 10% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 GLTO Damora Therapeutics, Inc. 1,193,708 2% SEC filing
IES Holdings, Inc. CIK 0001048268 RNGR Ranger Energy Services, Inc. 1,696,438 7.2% SEC filing
Fund 1 Investments, LLC CIK 0001959730 GCO GENESCO INC 425,310 3.9% SEC filing
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC CIK 0001164833 WPP WPP plc 81,920,781 7.6% SEC filing
HARRIS ASSOCIATES L P CIK 0000813917 PAYC Paycom Software, Inc. 3,257,774 6.8% SEC filing
Commodore Capital LP CIK 0001831942 PEPG PepGen Inc. 4,475,000 6.5% SEC filing
Fund 1 Investments, LLC CIK 0001959730 NVRI ENVIRI Corp 1,503,900 1.8% SEC filing
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC CIK 0001164833 WDAY WORKDAY, INC. 10,655,733 5.1% SEC filing
Fund 1 Investments, LLC CIK 0001959730 SFIX Stitch Fix, Inc. 1,970,000 1.6% SEC filing
Foraker John M. CIK 0001545600 OFRM Once Upon a Farm, PBC 2,762,546 6.5% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 IBIO iBio, Inc. 0 0% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 IPSC Century Therapeutics, Inc. 5,964,678 3.3% SEC filing
Commodore Capital LP CIK 0001831942 TYRA Tyra Biosciences, Inc. 2,475,000 4.2% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .